B96.6 Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere

Name of the Condition

• Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere

Summary

This code is used to identify conditions where Bacteroides fragilis is identified as the underlying cause of a disease that is classified elsewhere in the ICD-10-CM classification system. The bacteria are not the primary focus of the disease but contribute to its development or exacerbation. This code is applied when the specific bacterial agent is known but the primary disease is categorized under a different code.

Causes

The causes are attributed to Bacteroides fragilis, an anaerobic gram-negative bacterium that is part of the normal gut flora. It can act as an opportunistic pathogen, causing infections when it translocates from the gastrointestinal tract to other sites, particularly in the presence of disrupted mucosal barriers or compromised immunity.

Risk Factors

• Underlying chronic conditions that weaken the immune system, such as diabetes or inflammatory bowel disease.
• Recent antibiotic use, which may disrupt normal flora and allow bacterial overgrowth.
• Invasive medical procedures that introduce bacteria into sterile areas.
• Prolonged hospitalization, increasing exposure to healthcare-associated bacteria.
• Age extremes (very young or elderly), where immune function is typically reduced.

Symptoms

Symptoms vary depending on the primary disease and the site of infection. Common manifestations include fever, localized pain, or signs of systemic infection, such as sepsis, when the bacteria spread beyond the initial site.

Diagnosis

Diagnosis involves identifying Bacteroides fragilis through clinical or laboratory findings, such as culture or molecular testing of specimens from the infected site. The primary disease must be classified elsewhere, and the bacterial agent must be confirmed as a contributing factor.

Treatment Options

Treatment typically includes targeted antibiotic therapy, such as metronidazole or carbapenems, based on susceptibility testing. Supportive care may be necessary to manage symptoms or complications of the primary disease.

Prognosis and Follow-Up

Prognosis depends on the severity of the primary disease and the patient’s overall health. Follow-up may involve monitoring for resolution of infection, managing underlying conditions, and ensuring appropriate antibiotic therapy is completed.

Complications

Complications can include sepsis, abscess formation, or spread of infection to other organs, particularly in immunocompromised individuals or those with severe underlying conditions.

Lifestyle & Prevention

• Maintain good hygiene practices to reduce infection risk.
• Avoid unnecessary antibiotic use to preserve normal flora.
• Manage chronic conditions to support immune function.
• Seek prompt medical care for infections to prevent progression.

When to Seek Professional Help

Seek medical attention if symptoms of infection worsen, such as high fever, severe pain, or signs of systemic illness, especially in the context of a known or suspected B. fragilis infection.

Tips for Medical Coders

Use this code when Bacteroides fragilis is identified as the cause of a disease classified elsewhere. Ensure documentation supports the bacterial agent’s role in the condition and that the primary disease is coded separately. Verify that the code aligns with clinical findings and coding guidelines.